Mohamad Mohty, MD, PhD of Saint-Antoine Hospital, Paris, France gives an overview of the program of the 2017 Annual Meeting of the EBMT, which will be held between 26-29 March, 2017 in Marseilles, France (http://www.ebmt2017.org/). Prof. Mohty is the president of the European Society for Blood and Bone Marrow Transplantation (EBMT) and outlines the program for meeting. The program will cover all the relevant diseases and the hot topics in the various field. For example, there will be updates about all the novel agents, recent data and results in the field of multiple myeloma, updates on the use of novel small molecules before and after transplantation, and immunotherapy. Further, the meeting will see the introduction of high-level basic science biology sessions that will help further the attendees’ understanding of the biology of the diseases; this important to be able to improve the management of the diseases and innovate therapy according to Prof. Mohty. Apart from the physician program, there is also a nursing program and the second pharmacist day will take place; the focus of the pharmacist day will be the use of novel agents, side effects, and procurement. Moreover, top experts will debate controversial topics and there will be special sessions on, for example, how to get published and writing abstracts. There are also special sessions on the cooperation with pharma, which are important as Prof. Mohty points out, as they help improve everyone’s understanding of policy, compliance, and transparency. Furthermore, there will be an international collaboration session, which will include sessions on collaborating with Japan, China, Asia-Pacific and the Middle East. Prof. Mohty is optimistic that every attendee will find sessions of interest in this extensive program.
Recorded at the 2016 EBMT International Transplant Course (EBMT-ITC) in Barcelona, Spain.
